CTRI/2017/05/008699
Recruiting
Phase 2
Evaluation of commercial rapid diagnostic test kits for dengue infections in India
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Medecins Sans Frontieres
- Enrollment
- 300
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All archived samples of patients with confirmed Dengue by MAC ELISA stored at the CSTM, and stored samples of healthy patients. Stored samples of patients with other conditions to determine cross reactivity will also be used.
Exclusion Criteria
- •No exclusion criteria.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
Rapid diagnostic test for the detection of COVID-19 antibodiesCTRI/2020/07/026469HealthCubed India Pvt Ltd100
Completed
Not Applicable
Evaluation of a point-of-care test kit for the detection of periodontal pathogen in the treatment of periodontal disease: a multi-center studyPeriodontal diseaseJPRN-UMIN000011943Tokyo Dental College Nihon University School of Dentistry at Matsudo Tsurumi University Niigata University60
Active, not recruiting
Not Applicable
Evaluating a novel diagnostic test for the detection of Plasmodium infections at community level in The Gambia and Burkina FasoDiagnosis of Plasmodium infectionInfections and InfestationsISRCTN15263932MRC Unit The Gambia at LSHTM1,900
Completed
Not Applicable
Evaluation of the performance of novel rapid diagnostics for COVID-19 at point-of-careCOVID-19U07.1COVID-19, virus identifiedDRKS00021220niversitätsklinikum Heidelberg Sektion Klinische Tropenmedizin11,368
Not yet recruiting
Not Applicable
Evaluation study of a rapid test and treatments for Chagas disease in Bahia, BrazilMass ScreeningDrug therapyC01.920.625RBR-5zfkxdyCentro de Pesquisas Gonçalo Moniz